| # | Drug | Count |
|---|---|---|
| 0 | WARFARIN | 57 |
| 1 | METOPROLOL TARTRATE | 41 |
| 2 | METOPROLOL | 37 |
| 3 | PREDNISONE | 35 |
| 4 | ASPIRIN | 33 |
| 5 | ASPIRIN 325 MG | 33 |
| 6 | ASPIRIN 81 MG | 33 |
| 7 | METOPROLOL TARTRATE INJECTION | 33 |
| 8 | WARFARIN SODIUM | 30 |
| 9 | ACETAMINOPHEN | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAGRAXOFUSP | 2 | 0.0037 |
| 1 | DALTEPARIN SODIUM | 22 | 0.0021 |
| 2 | DIMENHYDRINATE | 22 | 0.0021 |
| 3 | BODY CLEANSER | 1 | 0.0014 |
| 4 | LEVOKETOCONAZOLE | 1 | 0.0013 |
| 5 | DIFLUNISAL | 1 | 0.0012 |
| 6 | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | 1 | 0.0012 |
| 7 | DISOPYRAMIDE PHOSPHATE | 1 | 0.0012 |
| 8 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 9 | NISOLDIPINE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 56 |
| 1 | Corticosteroid [EPC] | 49 |
| 2 | Proton Pump Inhibitor [EPC] | 46 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 33 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 32 |
| 5 | Loop Diuretic [EPC] | 30 |
| 6 | Expectorant [EPC] | 24 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 23 |
| 8 | Benzodiazepine [EPC] | 22 |
| 9 | Complement Inhibitor [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 2 | 0.0037 |
| 1 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 2 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 3 | Blood Viscosity Reducer [EPC] | 3 | 0.0007 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 3 | 0.0005 |
| 5 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 6 | Complement Inhibitor [EPC] | 21 | 0.0004 |
| 7 | Calcitonin [EPC] | 1 | 0.0003 |
| 8 | Vitamin D2 Analog [EPC] | 2 | 0.0003 |
| 9 | Anti-coagulant [EPC] | 1 | 0.0003 |